The significant progress made in psoriatic disease research since the launch of the National Psoriasis Foundation in 1967 has expanded our knowledge base and led to the development of life-changing treatment options. These options include:

• Topicals
• Phototherapy
• Systemics
• Biologics
• Oral Treatments

Even with all the information available today, providers may still have questions. For example:

• Are patients with chronic plaque psoriasis candidates for UVB phototherapy?
• Are all systemic treatments also biologics?
• What are the side effects of adalimumab?

Answers to these questions and more are easily accessible in the The Psoriasis and Psoriatic Arthritis Pocket Guide – Treatment Algorithms and Management Options.

After studying this handbook, physicians should be able to:

• Define the severity of psoriasis and develop an appropriate therapy plan.
• Explain the profound emotional, social and physical impact psoriatic disease has on the patient.
• Understand the important comorbidities associated with psoriasis.
• Differentiate psoriasis from other diseases after evaluating patients who present with similar types of skin lesions.
• Diagnose patients who have moderate disease (3% to 10% body involvement) and severe disease (>10% body involvement).

Updated August 2022 by the National Psoriasis Foundation.

Sponsor Acknowledgements

NPF would like to thank the following sponsors of The Psoriasis and Psoriatic Arthritis Pocket Guide:

Bristol-Myers Squibb
Janssen
UCB, Inc.